Impact of clopidogrel in coronary artery bypass grafting

Englberger, Lars; Faeh, Bettina; Berdat, Pascal A.; Eberli, Franz; Meier, Bernhard; Carrel, Thierry (2004). Impact of clopidogrel in coronary artery bypass grafting. European journal of cardio-thoracic surgery, 26(1), pp. 96-101. Elsevier Science B.V. 10.1016/j.ejcts.2004.03.030

26-1-96.pdf - Published Version
Available under License Publisher holds Copyright.

Download (106kB) | Preview

Objective: Clopidogrel has become the standard of care to prevent thrombotic complications following cardiological interventions, in particular intracoronary stenting. In addition, patients with aspirin intolerance and those with carotid and peripheral vascular disease are also increasingly treated with clopidogrel. Platelet inhibition may become a concern for hemostasis in patients treated with clopidogrel who need emergency and undelayed surgery. Methods: We prospectively analyzed the intra- and postoperative outcome of 505 consecutive patients who underwent isolated CABG and compared two groups: those with clopidogrel exposure until 72 h prior to surgery (n=136) with those without exposition to clopidogrel (n=369). Patients undergoing emergency surgery because of failed PTCA and cardiogenic shock, associated valvular surgery, redo-CABG, and those with additional platelet IIb/IIIa receptor inhibitor exposure were excluded. Patients who received aspirin and/or heparin treatment prior to surgery were not excluded. Results: Patients who received clopidogrel had a higher prevalence of angina class III or IV (67 vs 39%, P<0.01), received more often revascularization within 48 h (41 vs 14%, P=0.02), and had received more frequently stenting (57 vs 13%). Chest tube drainage was significantly increased during the first 24 h following CABG in the group of patients who had clopidogrel treatment (1485 vs 780 ml, P=0.003) These patients also required more transfusion of platelets and fresh frozen plasma. Overall re-exploration rate because of bleeding was significantly higher in the clopidogrel group (5.9 vs 1.2%, P<0.01). Platelets transfused before chest closure had a beneficial effect on preservation of the hemostasis. Conclusions: Clopidogrel exposure 3 days or less prior to CABG surgery significantly increases the risk of postoperative bleeding, the need for perioperative transfusion and the incidence of re-exploration. Surgery should be performed using standard heparinization and anti-fibrinolytic strategies but aggressive correction of platelets dysfunction is required before chest closure.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiovascular Surgery
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Englberger, Lars; Berdat, Pascal; Eberli, Franz; Meier, Bernhard and Carrel, Thierry


600 Technology > 610 Medicine & health




Elsevier Science B.V.




Marceline Brodmann

Date Deposited:

07 Oct 2020 08:25

Last Modified:

10 Mar 2021 15:07

Publisher DOI:





Actions (login required)

Edit item Edit item
Provide Feedback